No Detail Found!

Seroprevalence of Measles Igg Antibodies in Children of School Going Age.

Author(s)
Saiba Ferdoos Department of Biotechnology, University of Azad Jammu & Kashmir, Muzaffarabad, Pakistan
Shakir Khan Department of Biochemistry, Margalla Institute of Health Sciences, Rawalpindi, Pakistan
Zahid Azeem Department of Biochemistry, AJK Medical College, Muzaffarabad, Pakistan
Abdul Khaliq Naveed Department of Biochemistry, Islamic International Medical College, Rawalpindi, Pakistan
Ghazanfar Ali Department of Biotechnology, University of Azad Jammu & Kashmir, Muzaffarabad, Pakistan
Nazia Malik Department of Biotechnology, University of Azad Jammu & Kashmir, Muzaffarabad, Pakistan
Syed Sohail Zahoor Zaidi Virology, National Institute of Health, Islamabad, Pakistan
Abstract
Background: Measles is highly contagious infectious disease and considered to be leading cause of death among young children. Although vaccination process of measles is well ascertained but still its associated morbidity and mortality is high among children of developing countries. This study was designed to see the level of measles IgG in children in District Bagh of Azad Jammu & Kashmir. Methods: Measles IgG antibodies were screened in total of 250 school going children (4-8 years) in the District Bagh, Azad Jammu and Kashmir were enrolled. The subjects were grouped on age basis; Group A had children of 4-5 years, Group B comprised of children of 5-6 years, Group C contained children of 6-7 years and Group D had age 7-8 years. A The collected samples were transferred to the Molecular Virology Laboratories at National Institute of Health (NIH), Islamabad for detection of measles IgG antibodies. Measles antibodies were estimated by using kits for Enzyme Linked Immunosorbant Assay. Results: There were 10 (4%) children in Group A, 18 (7.2%) were in Group B, 42 (16.8%) were in Group C, and 180 (72%) children were in Group D. Out of 250 children 61 (24.4%) were detected as unprotected and 13 (5.2%) were at borderline and 176 (70.4%) had protective antibody level against the measles virus. Conclusion: Significant number of children is under potential risk to develop measles infection. No significant relation could be established between disease, age, and gender.
Publication Details
Page(s) 13-15
DOI DOI not available
Published Journal: Pakistan Journal of Physiology, Volume: 14, Issue: 1, Year: 2018

Request the full text from PASTIC

References
GaafarT,MoshniE,LievanoF., 2003.The challenge of achieving measles elimination in the Eastern Mediterranean Region by 2010,J Infect Dis 187 S164 -S171
OvsyannikovaIG,JacobsonRM,VierkantRA, 2004.Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination,Vaccine 22 1914 -20
CuttsFT,Henao-RestrepoA,OliveJM, 1999.Measles elimination: progress and challenges,Vaccine 17 47 -52
GdalevichM,RobinG,MimouniD,GrottoI,ShpilbergO,AshkenaziI., 2002.Measles antibody prevalence rates among young adults in Israel,Am J Infect Control 30 165 -9
BilkisMD,BarreroPR,MistchenkoAS, 2000.Measles resurgence in Argentina: 1997-1998 outbreak,Epidemiol Infect 124 289 -93
WhittleH,AabyP,SambB,CisseB,KantehF,Soumare M Simondon F. Poor, 1999.serologic responses five to seven years after immunization with high and standard titer measles vaccines,Pediatr Infect Dis J 18 53 -7
AliG,ZaidiSSZ,ZamanN., 2009.Seroprevalence of measles antibodies in children at school going age in Islamabad, Pakistan,Pak J Med Res 48 31 -5
TricouV,PagonendjiM,ManenguC,MutomboJ,MaboRO,GouandjikaI., 2013.Measles outbreak in Northern Central African Republic 3 years after the last national immunization campaign,BMC Infect Dis 13 103 -
DavidkinI,ValleM, 1998.Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: A 12-year follow-up in two cohorts,Vaccine 16 2052 -7
GozalanA,KorukluogluG,KurtogluD., 2005.Measles seroepidemiology in 3 cities in Turkey,Saudi Med J 26 1971 -7
KamatM,PyatiS,PildesRS, 1994.Measles antibody titers in early infancy,Arch Pediatr Adolesc Med 148 694 -8
ShannF,SteinhoffM, 1999.Vaccines for children in rich and poor countries,The Lancet 354 7 -11
IsikN,UzelN,GokcayG, 2003.Seroconversion after measles vaccination at nine and fifteen months of age,Pediatr Infect Dis 22 691 -5
PannutiCS,MorelloRJ,MoraesJC, 2004.Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic,Clin Diagn Lab Immunol 11 119 -22
CoxMJ,AzevedoRS,MassadE., 1998.Measles antibody levels in a vaccinated population in Brazil,Trans R Soc Trop Med Hyg 92 227 -30
TayilSE,ShazlyMK,AmrawySM,GhouneimFM,Abou KhatwaSA,MasoudGM, 1998.Sero-epidemiological study of measles after 15 years of compulsory vaccination in Alexandria, Egypt,East Mediter Health J 4 437 -47
MossongJ,O'CallaghanCJ,RatnamS., 2000.Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population,Vaccine 19 523 -9
SadaruddinA,GhafoorF,AlamS,SumeraN,KhanI,MohyuddinG, 2012.Seroprevalence of Measles Antibodies in School going Children in Pakistan,Pak J Med Res 51 38 -41
0

Citations

0

Downloads

49

Views